Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

9-deaza-5'-noraristeromycin.

Meral Tuncbilek1, Stewart W Schneller

  • 1Department of Chemistry, Auburn University, Auburn, AL 36849, USA.

Bioorganic & Medicinal Chemistry
|July 3, 2003
PubMed
Summary

Researchers synthesized 9-deaza-5'-noraristeromycin (2) through a 10-step process. This novel compound showed no antiviral activity and was not toxic to host cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis and biological evaluation of 6,9-disubstituted purine analogues inducing autophagy-mediated apoptosis and potentiating carboplatin response in high-grade serous ovarian cancer.

Bioorganic chemistry·2026
Same author

Biological evaluation of novel 6,9-disubstituted purine analogues in high-grade serous ovarian cancer cell lines.

Turkish journal of biology = Turk biyoloji dergisi·2026
Same author

Targeting Ovarian Cancer With Pyrimidine Nucleobase and Nucleoside Analogs: Synthesis, In Vitro Cytotoxic Activity, and Molecular Docking.

Archiv der Pharmazie·2025
Same author

Synthesis and cytotoxicity of novel 6,8,9-trisubstituted purine analogs against liver cancer cells.

Bioorganic & medicinal chemistry letters·2024
Same author

Exploration of novel 6,8,9-trisubstituted purine analogues: synthesis, in vitro biological evaluation, and their effect on human cancer cells.

Turkish journal of chemistry·2024
Same author

Newly synthesized 6-substituted piperazine/phenyl-9-cyclopentyl containing purine nucleobase analogs act as potent anticancer agents and induce apoptosis <i>via</i> inhibiting Src in hepatocellular carcinoma cells.

RSC medicinal chemistry·2023

Area of Science:

  • Medicinal Chemistry
  • Virology
  • Organic Synthesis

Background:

  • Nucleoside analogs are crucial in antiviral drug development.
  • Exploring novel nucleoside analogs can lead to new therapeutic agents.
  • The synthesis and evaluation of modified nucleosides are essential for identifying potent antiviral compounds.

Purpose of the Study:

  • To synthesize 9-deaza-5"-noraristeromycin (2).
  • To evaluate the antiviral activity of compound 2 against a broad spectrum of viruses.
  • To assess the cytotoxicity of compound 2 on viral host cells.

Main Methods:

  • Multi-step organic synthesis starting from (+)-(1R,4S)-4-t-butyldimethylsilyloxycyclopent-2-en-1-yl acetate.
  • Preparation of 9-deaza-5"-noraristeromycin (2) in 10 synthetic steps.
  • In vitro antiviral screening and cytotoxicity assays against various viruses and host cells.

Main Results:

  • Successful synthesis of 9-deaza-5"-noraristeromycin (2) was achieved.
  • Compound 2 exhibited no significant antiviral activity across a wide range of tested viruses.
  • No cytotoxicity was observed for compound 2 against the evaluated viral host cells.

Conclusions:

  • 9-deaza-5"-noraristeromycin (2) is a novel synthetic nucleoside analog.
  • The compound lacks antiviral efficacy.
  • Compound 2 demonstrates a favorable safety profile with no observed host cell toxicity.

Related Experiment Videos